Recent News

• 12.26.2025 - Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)
• 12.02.2025 - Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss
• 11.26.2025 - Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference
• 11.19.2025 - Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
• 11.17.2025 - Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

Recent Filings

• 12.09.2025 - 8-K Current report
• 12.09.2025 - EX-99.1 EX-99.1
• 12.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.05.2025 - 144 Report of proposed sale of securities
• 12.02.2025 - 8-K Current report
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.02.2025 - EX-99.1 EX-99.1
• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - EX-99.1 EX-99.1